Literature DB >> 21924559

The physiological substrates of fructosamine-3-kinase-related-protein (FN3KRP) are intermediates of nonenzymatic reactions between biological amines and ketose sugars (fructation products).

Benjamin S Szwergold1, Richard D Bunker, Kerry M Loomes.   

Abstract

The physiological function of fructosamine-3-kinase (FN3K) is relatively well understood. As shown in several studies, most conclusively by data on the FN3K-KO mouse, this enzyme breaks down compounds produced by the non-enzymatic glycation of proteins by D-glucose. In contrast with FN3K, very little is known about the function of the fructosamine-3-kinase-related-protein (FN3KRP) even though it has a 65% amino-acid sequence identity with FN3K. We do know that this enzyme is a kinase as evidenced by its ability to phosphorylate non-physiological compounds such a psicosamines, ribulosamines, erythrulosamines, and glucitolamines. However, FN3KRP does not phosphorylate any of the numerous Amadori products that are the physiological substrates of FN3K. The fact that FN3KRP is highly conserved in all vertebrates and present throughout nature suggests that it plays an important role in cellular metabolism and makes identification of its physiological substrates an important objective. In this paper, we propose that FN3KRP phosphorylates products resulting from a non-enzymatic glycation of amines by ketoses (fructation) that involves a 2,3-enolization and produces the stable Amadori intermediate, 2-amino-2-deoxy-D-ribo-hex-3-ulose (ADRH). This ketosamine is then phosphorylated to 2-amino-2-deoxy-D-ribo-hex-3-ulose-4-phosphate (ADRH-4-P). Since phosphates are much better leaving groups than hydroxyls, this destabilizes the C-2 amine bond and results in a spontaneous β-elimination of the phosphate to regenerate an unmodified amine with the concomitant production of 4-deoxy-2,3-diulose. Consequently, we postulate that the principal physiological function of FN3KRP is the breakdown of nonenzymatic fructation products. If confirmed in future studies, this hypothesis opens up new perspectives for an improved understanding of biological Maillard reactions and mechanisms for their control and/or reversal.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924559     DOI: 10.1016/j.mehy.2011.07.027

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  5 in total

Review 1.  The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.

Authors:  Jyotiska Chaudhuri; Yasmin Bains; Sanjib Guha; Arnold Kahn; David Hall; Neelanjan Bose; Alejandro Gugliucci; Pankaj Kapahi
Journal:  Cell Metab       Date:  2018-09-04       Impact factor: 27.287

2.  Exome-Wide Association Study Identifies FN3KRP and PGP as New Candidate Longevity Genes.

Authors:  Guillermo G Torres; Marianne Nygaard; Amke Caliebe; Hélène Blanché; Sophie Chantalat; Pilar Galan; Wolfgang Lieb; Lene Christiansen; Jean-François Deleuze; Kaare Christensen; Konstantin Strauch; Martina Müller-Nurasyid; Annette Peters; Markus M Nöthen; Per Hoffmann; Friederike Flachsbart; Stefan Schreiber; David Ellinghaus; Andre Franke; Janina Dose; Almut Nebel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-04-30       Impact factor: 6.053

3.  Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study.

Authors:  Xiao-Yan Huang; Li-Juan Yang; Xiang Hu; Xing-Xing Zhang; Xiao Gu; Lin-Jia Du; Zhi-Ying He; Xue-Jiang Gu
Journal:  World J Diabetes       Date:  2022-07-15

4.  Genetic Polymorphisms in the 3'-Untranslated Regions of SMAD5, FN3KRP, and RUNX-1 Are Associated with Recurrent Pregnancy Loss.

Authors:  Min-Jung Kwon; Ji-Hyang Kim; Jeong-Yong Lee; Eun-Ju Ko; Hyeon-Woo Park; Ji-Eun Shin; Eun-Hee Ahn; Nam-Keun Kim
Journal:  Biomedicines       Date:  2022-06-22

5.  Genome-wide transcript and protein analysis highlights the role of protein homeostasis in the aging mouse heart.

Authors:  Isabela Gerdes Gyuricza; Joel M Chick; Gregory R Keele; Andrew G Deighan; Steven C Munger; Ron Korstanje; Steven P Gygi; Gary A Churchill
Journal:  Genome Res       Date:  2022-03-11       Impact factor: 9.438

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.